Similarly to many human HER2+ breast cancers, it overexpresses the wild type form of Erbb2, which develops slowly, starting from foci of hyperplastic, dysplastic mammary epithelium and progressing to aggressive metastatic carcinoma [41]. The gene discussed is ERBB2; the disease is breast cancer.